Abstract:To determine whether the pharmacokinetics and pharmacodynamics of beta-blockade differ among racial groups, we gave 10 men of Chinese descent and 10 American white men 10, 20, 40, and 80 mg of propranolol every eight hours; the dosages were given in random order, and each dose was given for one day. The degree of beta-blockade was measured as the reduction in the heart rate and blood pressure in the supine and upright positions and during treadmill exercise testing. The Chinese subjects had at least a twofold greater sensitivity to the beta-blocking effects of propranolol than the white subjects, as indicated by the mean (±SEM) plasma concentrations producing a 20 percent reduction in the heart rate in both the supine position (197±31 vs. 536±58 nmol per liter; P<0.05) and the upright position (131±27 vs. 343±39 nmol per liter; P<0.05) and after exercise testing (96±12 vs. 185±23 nmol per liter; P<0.05). In addition, the Chinese subjects had much greater sensitivity to the hypotensive effects of propranolol, as shown by the concentrations that reduced blood pressure by 10 percent in the supine position (73±5 vs. 748±7 nmol per liter; P<0.01) and in the upright position (89±5 vs. 401±6 nmol per liter; P<0.01). No difference in beta-receptor density or affinity of lymphocytes was found between the groups. The Chinese group had a 45 percent higher free fraction of propranolol in plasma, which may have contributed to the increased drug effect but cannot explain it entirely. This group metabolized propranolol more rapidly than the white group, which resulted in a 76 percent higher clearance of an oral dose (3740±737 vs. 2125±214 ml per minute; P<0.05) because of increased metabolism through multiple metabolic pathways. We conclude that Chinese men have greater sensitivity than white men to the effects of propranolol on heart rate and blood pressure. Decreased protein binding may be responsible in part, but most of the effect remains to be explained. (N Engl J Med 1989; 320:565–70.)

No Sex Difference In Overall P-Glycoprotein Activity As Assessed By Talinolol Disposition In Humans

Sex-Differences In Pharmacokinetics Of Oral Propranolol In Healthy Chinese Volunteers

Lack of Effect of Continuous Glycyrrhizin Administration on the Pharmacokinetics of the P-Glycoprotein Substrate Talinolol in Healthy Volunteers

Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers.

Effect of duloxetine on the pharmacokinetics of talinolol in humans

Mdr1 Genotype Do Not Influence the Absorption of A Single Oral Dose of 100 Mg Talinolol in Healthy Chinese Males

Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.

Effect of Schisandra Chinensis Extract and Ginkgo Biloba Extract on the Pharmacokinetics of Talinolol in Healthy Volunteers.

CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects

Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants

Effects of Curcumin on the Pharmacokinetics of Talinolol in Human with ABCB1 Polymorphism.

Differences in Stereoselective Disposition of Propranolol Do Not Explain Sensitivity Differences Between White and Chinese Subjects: Correlation Between the Clearance of (−)- and (+)-Propranolol

Effect of Quercetin on P-glycoprotein Transport Ability in Chinese Healthy Subjects

Racial Differences in Drug Response

Effects of Regular Consumption of RRR-tocopherol on the Activity of CYP3A 4 in Vivo

Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population: Polymorphism and gender differences of CYP1A2

No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects.

HPLC-MS determination of talinolol in human plasma and application to pharmacokinetic studies on Chinese healthy volunteers

Effect of 18Α-Glycyrrhetinic Acid and 18Β-Glycyrrhetinic Acid on Outward Transport of Talinolol in Caco-2 Cell Monolayers

Gender-related Differences in Pharmacokinetics of Novel Prodrug of Triptolide MC002 in Rats

Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).